Astrogenetix

Astrogenetix is the first biotechnology company to develop novel therapeutic products in the microgravity environment of space. Founded in 2008 by its parent company Astrotech Corporation (NASDAQ: ASTC) (formerly SPACEHAB), Astrogenetix was one of the first commercial entities to sign a Space Act Agreement (SAA) with NASA for the use of the International Space Station.